Retraction

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker

Paper Information

Record ID:

44026

Author(s):

Feng Li
Feiran Wang
Changlai Zhu
Qun Wei
Tianyi Zhang
You Lang Zhou

Journal:

International Journal of Nanomedicine ( Taylor and Francis - Dove Press )

Publication Date:

April 13, 2018

Retraction Date:

April 14, 2023 (2.6 years years ago)

Subjects:

Broad Categories:
Biology Genetics

Specific Fields:
Biology - Cancer Biology - Cellular Genetics

Institutions:

Country:

🇨🇳 China

Article Type:

Research Article

Publisher:

Taylor and Francis - Dove Press

Open Access:

Yes

DOI:

10.2147/IJN.S157805

PubMed ID:

29713162

Retraction PubMed ID:

37081943

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.2147/IJN.S415737

Additional Notes:

see https://pubpeer.com/publications/4EE26B0ECEE73AF556F29116F24C13 and https://pubpeer.com/publications/3AD4F9316DE5AD0B28C0788A38ABD2

Citations (42)

42

Total Citations

5

Post-Retraction
(11.9%)

37

Pre-Retraction

0

Same Day

Post-Retraction Citation Analysis

0 Within 30 days

4 Within 1 year

0 After 2+ years

536 Days since retraction (latest)

MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential

Fenfen Guo, Hong Li, Jingjing Wang et al. (8 authors)

Cancer Management and Research Open Access

Published: Oct 2024
2 citations

536 days after retraction

Engineering HEK293T cell line by lentivirus to produce miR34a-loaded exosomes

Sahar Abdi Sarkami, Sajjad Molavipordanjani, Saeid Abediankenari et al. (7 authors)

Molecular Biology Reports Open Access

Published: Sep 2023
2 citations

141 days after retraction

Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors

Sanya Batheja, Rakesh Kumar Sahoo, Sofiya Tarannum et al. (8 authors)

Biochimica et Biophysica Acta (BBA) - General Subjects

Published: Aug 2023
4 citations

138 days after retraction

Nanoparticle-mediated delivery of microRNAs-based therapies for treatment of disorders

Soudeh Ghafouri‐Fard, Hamed Shoorei, Leili Noferesti et al. (7 authors)

Pathology - Research and Practice Open Access

Published: Jul 2023
13 citations

80 days after retraction

The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis

Y. Liu, Jingwen Li, Junying Li et al. (8 authors)

Expert Review of Anticancer Therapy

Published: Jun 2023

52 days after retraction

Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential

Han Qin, Mengchen Wang, Xi Dong et al. (6 authors)

Frontiers in Immunology Open Access

Published: Oct 2022
24 citations

186 days before retraction

Evaluation of Circulating MicroRNA-222 in Patients with Chronic Hepatitis B virus Infection as a Potential Noninvasive Diagnostic Biomarker

Fedra Mokhtari, Hami Kaboosi, Seyed Reza Mohebbi et al. (5 authors)

Iranian Journal of Medical Microbiology Open Access

Published: Oct 2022
1 citation

195 days before retraction

MiR-574-5p promotes cell proliferation by negatively regulating small C-terminal domain phosphatase 1 in esophageal squamous cell carcinoma.

Chunming Zhao, Jialin Liu, Yong Xu et al. (12 authors)

DOAJ (DOAJ: Directory of Open Access Journals)

Published: Oct 2022
3 citations

195 days before retraction

CircFMN2 Boosts Sorafenib Resistance in Hepatocellular Carcinoma Cells via Upregulating CNBP by Restraining Ubiquitination

Fan Chen, Xiaoli Zhu, Qi Zhou et al. (4 authors)

Journal of Oncology Open Access

Published: Jul 2022
7 citations

267 days before retraction

Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance

Jong Hyuk Yun, Moo Jun Baek, Hae Il Jung

Korean Journal of Clinical Oncology Open Access

Published: Jun 2022
5 citations

288 days before retraction

<scp>miRNAs</scp> are now starring in “<i>No Time to Die</i>: Overcoming the chemoresistance in cancer”

Anmol Bhatia, Atul Kumar Upadhyay, Siddharth Sharma

IUBMB Life

Published: Jun 2022
3 citations

309 days before retraction

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma

Xiaochang Wu, Renrui Wan, LingYan Ren et al. (6 authors)

The Turkish Journal of Gastroenterology Open Access

Published: May 2022
8 citations

323 days before retraction

Role of let7-g and miR-221 level as potential predictors for overall survival of hepatocellular carcinoma patients

Abdel Hady A. Abdel Wahab, Manal M. Hussein, Samia A. Shouman et al. (6 authors)

Arab Journal of Gastroenterology

Published: Apr 2022
1 citation

356 days before retraction

miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review

Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo et al. (25 authors)

Molecular Therapy — Nucleic Acids Open Access

Published: Feb 2022
95 citations

427 days before retraction

Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review

Shadab Md, Nabil A. Alhakamy, Shahid Karim et al. (6 authors)

Pharmaceutics Open Access

Published: Dec 2021
6 citations

492 days before retraction

Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update

Adil Ali Sayyed, Piyush Gondaliya, Palak Bhat et al. (7 authors)

Current Pharmaceutical Design

Published: Nov 2021
14 citations

521 days before retraction

Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis

Zhaoxia Sun, Li Zhao, Shuang Wang et al. (4 authors)

Annals of Hepatology Open Access

Published: Oct 2021
7 citations

533 days before retraction

The Role of MicroRNA 143 and MicroRNA 206 in The Regulation of Apoptosis in Mouse Lukemia Cancer Cells and Spermatogonial Cells.

Azar Shams, Ronak Shabani, Mohammad Najafi et al. (10 authors)

PubMed

Published: Oct 2021
2 citations

560 days before retraction

The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis

Wenfeng Liu, Keshu Hu, Feng Zhang et al. (7 authors)

The International Journal of Biological Markers Open Access

Published: Aug 2021
7 citations

621 days before retraction

MicroRNA Therapeutics in Cancer: Current Advances and Challenges

Soha Reda El Sayed, Justine Cristante, Laurent Guyon et al. (6 authors)

Cancers Open Access

Published: May 2021
142 citations

685 days before retraction

Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma

Bornika Roy, Sampa Ghose, Subhrajit Biswas

Seminars in Cell and Developmental Biology

Published: Apr 2021
47 citations

718 days before retraction

Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives

Devaraj Ezhilarasan

European Journal of Pharmacology

Published: Jan 2021
16 citations

833 days before retraction

miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer

Xiaoli Wei, Jiejie Zhu, Yiyin Zhang et al. (6 authors)

Journal of Cancer Open Access

Published: Jan 2021
5 citations

833 days before retraction

Regulation of ferroptosis by non‑coding RNAs in the development and treatment of cancer (Review)

Yajun Luo, Qingmei Huang, Bin He et al. (6 authors)

Oncology Reports Open Access

Published: Nov 2020
42 citations

890 days before retraction

MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury

Jovana Markovic, Amar Deep Sharma, Asha Balakrishnan

Cells Open Access

Published: Jul 2020
30 citations

995 days before retraction

Development of MicroRNAs as Potential Therapeutics against Cancer

Noraini Abd-Aziz, Nur Izyani Kamaruzman, Chit Laa Poh

Journal of Oncology Open Access

Published: Jul 2020
75 citations

1003 days before retraction

Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment

Archu Singh, Sadat Shafi, Tanya Upadhyay et al. (6 authors)

Current Topics in Medicinal Chemistry

Published: Jun 2020
9 citations

1024 days before retraction

Progress and prospects of biomarkers in�primary liver cancer (Review)

Yuxue Gao, Tongwang Yang, Jiming Yin et al. (8 authors)

International Journal of Oncology Open Access

Published: Apr 2020
70 citations

1108 days before retraction

Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma

Lisa Linck, Claus Hellerbrand, Anja‐Katrin Bosserhoff et al. (4 authors)

Cells Open Access

Published: Jan 2020
17 citations

1198 days before retraction

miRNA-based biomarkers, therapies, and resistance in Cancer

Boxue He, Zhenyu Zhao, Qidong Cai et al. (11 authors)

International Journal of Biological Sciences Open Access

Published: Jan 2020
478 citations

1199 days before retraction

MicroRNA dysregulation interplay with childhood abdominal tumors

Karina Bezerra Salomão, Julia Alejandra Pezuk, Graziella Ribeiro de Sousa et al. (7 authors)

Cancer and Metastasis Reviews

Published: Dec 2019
14 citations

1230 days before retraction

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman et al. (10 authors)

Expert Opinion on Therapeutic Targets

Published: Oct 2019
88 citations

1264 days before retraction

The Therapeutic Potential of miR-7 in Cancers

Miao Li, Meng Pan, Chengzhong You et al. (4 authors)

Mini-Reviews in Medicinal Chemistry

Published: Sep 2019
14 citations

1318 days before retraction

Noncoding RNAs in cancer therapy resistance and targeted drug development

Wentao Wang, Cai Han, Yu-Meng Sun et al. (5 authors)

Journal of Hematology & Oncology Open Access

Published: Jun 2019
237 citations

1407 days before retraction

Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line

Serap Yalçın

Pharmaceutical Development and Technology

Published: Jun 2019
28 citations

1410 days before retraction

Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis

Huayu Wu, Kai-teng Cai, Jie Ma et al. (7 authors)

Pathology - Research and Practice

Published: Apr 2019
11 citations

1446 days before retraction

Overexpression of MTHFD1 in hepatocellular carcinoma predicts poorer survival and recurrence

Hua Yu, Han Wang, Hairong Xu et al. (8 authors)

Future Oncology

Published: Apr 2019
34 citations

1457 days before retraction

MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma

Seyed Mostafa Parizadeh, Reza Jafarzadeh Esfehani, Maryam Ghandehari et al. (9 authors)

Current Drug Targets

Published: Mar 2019
24 citations

1498 days before retraction

Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs

Margherita Alba Carlotta Pomatto, Benedetta Bussolati, Sergio D’Antico et al. (7 authors)

Molecular Therapy — Methods & Clinical Development Open Access

Published: Jan 2019
200 citations

1556 days before retraction

Gene therapy: recent progress and perspectives

Ilda Czobor Barbu

Elsevier eBooks

Published: Jan 2019
1 citation

1564 days before retraction

MicroRNA 221/222 cluster kicks out Timp-3 to inflame the liver

Rossella Menghini, Massimo Federici

EBioMedicine Open Access

Published: Oct 2018
3 citations

1637 days before retraction

Potential clinical value and putative biological function of miR‑122‑5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data

Dong‐yue Wen, Jiacheng Huang, Jie‐Yu Wang et al. (7 authors)

Oncology Letters Open Access

Published: Sep 2018
29 citations

1659 days before retraction

Related Records

This article has multiple records in the database due to different notices:

Record #44028

Oct 27, 2020

Correction

Quick Stats

Total Citations: 42

Years Since Retraction: 2.6 years

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice